Cost effectiveness of vildagliptin versus glimepiride as add-on treatment to metformin for the treatment of diabetes mellitus type 2 patients in Greece

OBJECTIVES: This study was designed to assess the cost-effectiveness of vildagliptin versus glimepiride as add-on to metformin in the management of type 2 diabetes mellitus (T2DM) patients in the Greek healthcare setting. METHODS: A cost-effectiveness model was designed, using MS Excel, to compare t...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cost Eff Resour Alloc
Main Authors: Kousoulakou, Hara, Hatzikou, Magdalini, Baroutsou, Varvara, Yfantopoulos, John
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2017
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5586069/
https://ncbi.nlm.nih.gov/pubmed/28904527
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12962-017-0082-7
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados